IP Forecast: Ferring, Lupin To Face Off In Clenpiq Patent Trial
Ferring Pharmaceuticals is scheduled to go head-to-head with generic drugmaker Lupin in a Delaware bench trial next week over patents connected to the first U.S. Food and Drug Administration-approved prescription "ready-to-drink"...To view the full article, register now.
Already a subscriber? Click here to view full article